FDA Implements Daily Updates on Adverse Event Data for Enhanced Transparency

The U.S. Food and Drug Administration (FDA) has advanced its public health efforts by now releasing adverse event data from its reporting system on a daily basis. This development represents a significant shift from the previous quarterly updates, aiming to provide real-time information on medication and product safety concerns.

The FDA’s Adverse Event Reporting System (FAERS) compiles reports from healthcare professionals, consumers, and manufacturers regarding adverse reactions, serious medication errors, and quality issues related to prescription drugs and biologics. These reports are now accessible daily through the FAERS Public Dashboard, enabling quicker identification of potential safety signals.

FDA Commissioner Marty Makary, M.D., M.P.H., emphasized that the change is part of the agency’s effort to improve transparency and streamline access to vital safety information. "People navigating the government’s cumbersome adverse event reports should not have to wait for months for this information," he stated.

This initiative is part of the FDA’s broader data modernization strategy, which seeks to enhance the frequency and speed of adverse event reporting across all its systems. Over two million reports are received annually, highlighting the importance of timely data for protecting public health.

The shift encourages health care providers, consumers, and manufacturers to report adverse events via the FDA MedWatch website. The heightened reporting and publication frequency aim to facilitate faster analysis and response to safety alerts.

For more details, visit the FDA's official announcement on this new reporting process.